PTEN pathway - PubMed (original) (raw)

Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway

Lu Kong et al. Carcinogenesis. 2012 Apr.

Abstract

Prostate cancer (PC) remains the second most common cause of cancer-related death in Western countries. A previous proteomics study suggested that the nuclear membrane protein lamin A/C to be a maker to discriminate low- and high-Gleason score tumors and to identify high-risk cancers. To characterize its function in PC cells, we performed a detailed expression analysis in PC tissue and explored the consequences of down or upregulation of lamin A/C in PC cells. Our results confirm an increased lamin A/C protein expression in high-risk cancers and show association of expression with tumor cell formations at the invasion fronts of tumors and in invasion 'spearheading' tumor cell clusters. In the prostate tumor cell lines, LNCaP, DU145, and PC3 small hairpin RNA knockdown or overexpression of lamin A/C resulted in inhibition or stimulation, respectively, of cell growth, colony formation, migration and invasion. Further mechanism studies suggested that the lamin A/C-related malignant behavior is regulated through modulation of the phosphoinositide 3-kinase (PI3K)/AKT/PTEN signaling pathway. Western blot results indicated that knockdown or overexpression of lamin A/C decreased or increased, respectively, protein levels of the PI3K subunits p110 and p85 in all three cell lines; phosphor-AKT in the PTEN-negative cell lines LNCaP and PC3, and, increased or decreased, respectively, PTEN protein levels in PTEN-positive DU145 cells. Together, our data suggest that lamin A/C proteins are positively involved in malignant behavior of PC cells through the PI3K/AKT/PTEN pathway. Lamin A/C may represent a new oncogenic factor and a novel therapeutic target for PC.

PubMed Disclaimer

Cited by

LMNA functions as an oncogene in hepatocellular carcinoma by regulating the proliferation and migration ability.
Liu H, Li D, Zhou L, Kan S, He G, Zhou K, Wang L, Chen M, Shu W. Liu H, et al. J Cell Mol Med. 2020 Oct;24(20):12008-12019. doi: 10.1111/jcmm.15829. Epub 2020 Sep 8. J Cell Mol Med. 2020. PMID: 32896989 Free PMC article.
T63 induces apoptosis in nasopharyngeal carcinoma cells through mitochondrial dysfunction and inhibition of PI3K/Akt signaling pathway.
Liu Q, Chen W, Yang H. Liu Q, et al. Transl Cancer Res. 2020 Aug;9(8):4635-4645. doi: 10.21037/tcr-20-1677. Transl Cancer Res. 2020. PMID: 35117827 Free PMC article.
LMNB1, a potential marker for early prostate cancer progression.
Hong JH, Liang ST, Wang AS, Yeh CM, Huang HP, Sun CD, Zhang ZH, Lu SY, Chao YH, Chen CH, Pu YS. Hong JH, et al. Am J Cancer Res. 2022 Jul 15;12(7):3390-3404. eCollection 2022. Am J Cancer Res. 2022. PMID: 35968338 Free PMC article.
Nuclear assembly as a target for anti-cancer therapies.
Gorjánácz M. Gorjánácz M. Nucleus. 2014 Jan-Feb;5(1):47-55. doi: 10.4161/nucl.27928. Epub 2014 Jan 27. Nucleus. 2014. PMID: 24637400 Free PMC article. Review.
Nuclear mechanics and mechanotransduction in health and disease.
Isermann P, Lammerding J. Isermann P, et al. Curr Biol. 2013 Dec 16;23(24):R1113-21. doi: 10.1016/j.cub.2013.11.009. Curr Biol. 2013. PMID: 24355792 Free PMC article. Review.

Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway - PubMed (original) (raw)